Gene Expression Insights into Cytarabine Resistance in Acute Myeloid Leukemia: The Role of Cytokines
Cancer Genomics - Proteomics · 2025
DOI: 10.21873/cgp.20533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2025. Verfasst von Chieh-Ming Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Cytarabine, Leukemia, Myeloid, Acute, Drug Resistance, Neoplasm, Cytokines. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Cytarabine is the main chemotherapy agent used to treat acute myeloid leukemia (AML), but drug resistance remains a major challenge. Imbalances in cytokine secretion are known to play a role in the survival and proliferation of AML blast cells. While numerous studies have investigated cytokine secretion in AML, the precise role of cytokines in the pathogenesis of AML remains unclear. This study aimed to compare cytokine-related gene expression in parental and resistant HL60 cells and assess their prognostic relevance in AML. MATERIALS AND METHODS: This study compared gene expression profiles of parental HL60 and R-HL60 cells by analyzing gene expression arrays. Further, the correlation between the differential expression genes (DEGs) and overall survival in patients with AML was obtained from the Cancer Genome Atlas (TCGA) database, and the expression of genes was validated by quantitative PCR (QPCR). RESULTS: Our results showed that twenty-six genes involved in cytokine regulation were significantly different between HL60 and R-HL60 cells. The DEGs associated with cytokine production between parental HL60 and R-HL60 was subjected to a functional enrichment analysis by ShinyGO. The expression of BCL3, OAS3, RELB, AIM2, NFKB2, CLEC9A, and OAS2 involved in the regulation of cytokine production was associated with survival probability of AML patient in the TCGA database. Among them, the expression of BCL3, OAS3, RELB, AIM2, and NFKB2 genes in R-HL60 cells was higher than that in HL-60 cells. CONCLUSION: This study identified key genes involved in cytokine dysregulation in cytarabine-resistant HL60 cells, providing potential targets for overcoming drug resistance in AML. These findings offer new avenues for the development of more effective therapies for relapsed or refractory AML patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.
- Department of Healthcare Administration, Asia University, Taichung, Taiwan, R.O.C.
- Department of Pediatrics, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.
- Department of Pediatrics, Kaohsiung Medical University Gangshan Hospital, Kaohsiung, Taiwan, R.O.C.
- School of Dentistry, China Medical University, Taichung, Taiwan, R.O.C.
- Institute of Oral Biology, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.
Zitieren
APA
Lee, C. M., Shih, Y. H., Chen, I. C., Shieh, T. M., Yeh, C. Y., & Tseng, Y. H. (2025). Gene Expression Insights into Cytarabine Resistance in Acute Myeloid Leukemia: The Role of Cytokines. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20533
Vancouver
Lee CM, Shih YH, Chen IC, Shieh TM, Yeh CY, Tseng YH. Gene Expression Insights into Cytarabine Resistance in Acute Myeloid Leukemia: The Role of Cytokines. Cancer Genomics - Proteomics. 2025. doi:10.21873/cgp.20533
BibTeX
@article{Lee2025,
author = {Lee, Chieh-Ming and Shih, Yin-Hwa and Chen, I-Chen and Shieh, Tzong-Ming and Yeh, Chung-Yu and Tseng, Yu-Hsin},
title = {Gene Expression Insights into Cytarabine Resistance in Acute Myeloid Leukemia: The Role of Cytokines},
journal = {Cancer Genomics - Proteomics},
year = {2025},
doi = {10.21873/cgp.20533}
}
EUVIMED